Scott Filler is an Infectious Disease physician affiliated with University of California, Los Angeles. OpenAlex indexes 328 publications with 28,066 citations (h-index 87); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
21840 Normandie Ave
Torrance, CA 905022047
Telephone
310-222-5101Registry record last updated 8 Jul 2007.
Clinical trials
- Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda
Sponsor: University of California, San Francisco
- Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi
Sponsor: Centers for Disease Control and Prevention
- A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20253 payments
- Shionogi IncProgram year20253 payments
- Astellas Pharma US IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- Epigenomic Mechanisms & STAT Networks in Persistent CA Candidemia
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2026$285,264U19AI172713 - Transcriptional networks governing A. fumigatus virulence
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2025$657,546R01AI162802 - Epigenomic Mechanisms & STAT Networks in Persistent CA Candidemia
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2025$385,216U19AI172713
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”